-
Symbol
-
BBNX on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
3,570,113 shares
-
Security Ownership %
-
8.2%
Sands Capital Life Sciences Pulse Fund II. L.P. ownership in Beta Bionics, Inc. Common Stock, par value $0.0001 per share (BBNX)
13 Aug 2025 - Sands Capital Life Sciences Pulse Fund II. L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,570,113 shares of Beta Bionics, Inc. Common Stock, par value $0.0001 per share (BBNX).
This represents 8.2% ownership of the company.
In their previous filing dated 09 Apr 2025, Sands Capital Life Sciences Pulse Fund II, L.P. had reported owning 3,154,409 shares, indicating an increase of +13%.
.